Alumis (ALMS) News Today $5.17 +0.04 (+0.78%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$5.13 -0.04 (-0.77%) As of 02/21/2025 06:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Analysts Set Alumis Inc. (NASDAQ:ALMS) Target Price at $26.57February 22 at 1:11 AM | americanbankingnews.comAlumis Inc. Approves New Severance and Control PlanFebruary 21 at 4:48 PM | tipranks.comACELYRIN shares surge on buyout interestFebruary 21 at 11:55 AM | in.investing.comActivist investor threatens Peninsula drug maker's merger plansFebruary 21 at 11:55 AM | bizjournals.comAlumis (ALMS) to Release Earnings on WednesdayAlumis (NASDAQ:ALMS) will be releasing earnings before the market opens on Wednesday, February 26, Financial Modeling Prep reports.February 21 at 2:06 AM | marketbeat.comAlumis Inc. (NASDAQ:ALMS) Given Consensus Recommendation of "Buy" by AnalystsShares of Alumis Inc. (NASDAQ:ALMS - Get Free Report) have been assigned a consensus rating of "Buy" from the nine ratings firms that are presently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a buy rating and two have given a strong buy rating to thFebruary 19 at 2:20 AM | marketbeat.comOppenheimer Reaffirms Their Buy Rating on Alumis Inc. (ALMS)February 11, 2025 | markets.businessinsider.comAnalysts Offer Insights on Materials Companies: Alumis Inc. (ALMS) and Martin Marietta Materials (MLM)February 11, 2025 | markets.businessinsider.comAlumis to Present at Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 10, 2025 | globenewswire.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of ACELYRIN, INC.February 7, 2025 | prnewswire.comAfter big IPO, Peninsula biotech plots merger, big clinical trial readoutsFebruary 7, 2025 | bizjournals.comH.C. Wainwright cuts Alumis stock target to $19, maintains Buy ratingFebruary 7, 2025 | msn.comWe're Keeping An Eye On Alumis' (NASDAQ:ALMS) Cash Burn RateFebruary 7, 2025 | finance.yahoo.comAlumis and Acelyrin to merge in all-stock dealFebruary 7, 2025 | msn.comAlumis price target lowered to $19 from $26 at H.C. WainwrightFebruary 7, 2025 | markets.businessinsider.comAlumis price target lowered to $17 from $25 at BairdFebruary 7, 2025 | markets.businessinsider.comAlumis (NASDAQ:ALMS) Price Target Cut to $19.00 by Analysts at HC WainwrightHC Wainwright dropped their price objective on shares of Alumis from $26.00 to $19.00 and set a "buy" rating on the stock in a report on Friday.February 7, 2025 | marketbeat.comLeerink Partnrs Issues Positive Outlook for Alumis EarningsAlumis Inc. (NASDAQ:ALMS - Free Report) - Equities researchers at Leerink Partnrs increased their FY2025 earnings per share estimates for Alumis in a research report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now anticipates that the company will post earnings of ($4.79)February 7, 2025 | marketbeat.comALMS Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Alumis Inc. is Fair to ShareholdersFebruary 6, 2025 | businesswire.comAlumis Inc trading halted, news pendingFebruary 6, 2025 | markets.businessinsider.comAlumis Inc. Announces Merger with ACELYRIN, Inc.February 6, 2025 | tipranks.comACELYRIN, INC. Announces Merger with Alumis Inc.February 6, 2025 | tipranks.comAlumis Inc. and ACELYRIN, Inc. Announce Definitive Merger Agreement to Advance Late-Stage Pipeline and Clinical DevelopmentFebruary 6, 2025 | quiverquant.comAlumis Inc. and ACELYRIN, INC. Announce Definitive Merger Agreement to Enhance Late-Stage Pipeline and Long-Term Stockholder ValueFebruary 6, 2025 | quiverquant.comAlumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated DiseasesFebruary 6, 2025 | globenewswire.comLeerink Partnrs Forecasts Alumis FY2029 EarningsAlumis Inc. (NASDAQ:ALMS - Free Report) - Equities researchers at Leerink Partnrs issued their FY2029 earnings estimates for shares of Alumis in a research note issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will post earnings of ($1.61) per share forFebruary 6, 2025 | marketbeat.comAlumis (ALMS) Expected to Announce Earnings on WednesdayAlumis (NASDAQ:ALMS) will be releasing earnings before the market opens on Wednesday, February 12, Financial Modeling Prep reports.February 5, 2025 | marketbeat.comOppenheimer Initiates Coverage of Alumis (ALMS) with Outperform RecommendationJanuary 31, 2025 | msn.comAlumis draws Outperform at Oppenheimer on valuation disconnectJanuary 30, 2025 | msn.comWhy Alumis (ALMS) Stock Is Advancing TodayJanuary 30, 2025 | msn.comAlumis initiated with an Outperform at OppenheimerJanuary 30, 2025 | markets.businessinsider.comAnalysts Offer Insights on Materials Companies: Alumis Inc. (ALMS) and Corning (GLW)January 30, 2025 | markets.businessinsider.comAlumis (NASDAQ:ALMS) Coverage Initiated at OppenheimerOppenheimer assumed coverage on Alumis in a report on Thursday. They issued an "outperform" rating and a $32.00 price objective for the company.January 30, 2025 | marketbeat.comAlumis appoints Danilkowicz as CCO, Klein as CLOJanuary 29, 2025 | markets.businessinsider.comAlumis Inc. Strengthens Leadership Team with Appointment of Jack Danilkowicz as Chief Commercial Officer and Promotion of Sara Klein to Chief Legal OfficerJanuary 28, 2025 | quiverquant.comAlumis Strengthens Leadership Team with Key AppointmentsJanuary 28, 2025 | globenewswire.comAlumis Inc. (NASDAQ:ALMS) Given Consensus Rating of "Buy" by BrokeragesAlumis Inc. (NASDAQ:ALMS - Get Free Report) has been assigned an average rating of "Buy" from the eight ratings firms that are currently covering the firm, MarketBeat.com reports. Six research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation toJanuary 25, 2025 | marketbeat.comCantor Fitzgerald Predicts Alumis FY2025 EarningsAlumis Inc. (NASDAQ:ALMS - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Alumis in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst E. Schmidt expects that the company will earn ($4.13) per share for the yJanuary 23, 2025 | marketbeat.comGeode Capital Management LLC Purchases Shares of 305,680 Alumis Inc. (NASDAQ:ALMS)Geode Capital Management LLC bought a new stake in shares of Alumis Inc. (NASDAQ:ALMS - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 305,680 shares of the company's stock, valued at approximately $3,266,000. GeodJanuary 7, 2025 | marketbeat.comAlumis Inc.’s ESK-001: A Promising TYK2 Inhibitor with Blockbuster PotentialJanuary 6, 2025 | markets.businessinsider.comAlumis' (ALMS) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $26.00 price target on shares of Alumis in a research report on Monday.January 6, 2025 | marketbeat.comState Street Corp Makes New Investment in Alumis Inc. (NASDAQ:ALMS)State Street Corp purchased a new stake in Alumis Inc. (NASDAQ:ALMS - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 81,059 shares of the company's stock, valued at approximately $866,000. State Street CJanuary 3, 2025 | marketbeat.comAlumis Inc. (NASDAQ:ALMS) Receives Average Rating of "Buy" from BrokeragesShares of Alumis Inc. (NASDAQ:ALMS - Get Free Report) have earned a consensus rating of "Buy" from the eight analysts that are currently covering the stock, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the cDecember 31, 2024 | marketbeat.comOwning 32% shares,hedge funds owners seem interested in Alumis Inc. (NASDAQ:ALMS),December 28, 2024 | uk.finance.yahoo.comStifel Financial Corp Invests $931,000 in Alumis Inc. (NASDAQ:ALMS)Stifel Financial Corp purchased a new stake in Alumis Inc. (NASDAQ:ALMS - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 87,185 shares of the company's stock, valued at apprDecember 24, 2024 | marketbeat.comAlumis announces Phase 1 data for CNS penetrant TYK2 inhibitor, A-005December 20, 2024 | markets.businessinsider.comAlumis (NASDAQ:ALMS) Given "Buy" Rating at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $26.00 price objective on shares of Alumis in a research report on Friday.December 20, 2024 | marketbeat.comAlumis Announces Positive Phase 1 Data for CNS Penetrant TYK2 Inhibitor, A-005December 19, 2024 | markets.businessinsider.comCharles Schwab Investment Management Inc. Takes $1.16 Million Position in Alumis Inc. (NASDAQ:ALMS)Charles Schwab Investment Management Inc. purchased a new position in Alumis Inc. (NASDAQ:ALMS - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 108,593 shares of the company's stock, valued at approximately $1,160December 18, 2024 | marketbeat.comAlumis Inc.'s (NASDAQ:ALMS) Lock-Up Period Set To Expire on December 25thAlumis' (NASDAQ:ALMS - Get Free Report) lock-up period is set to expire on Wednesday, December 25th. Alumis had issued 13,125,000 shares in its IPO on June 28th. The total size of the offering was $210,000,000 based on an initial share price of $16.00. After the expiration of Alumis' lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.December 18, 2024 | marketbeat.com Get Alumis News Delivered to You Automatically Sign up to receive the latest news and ratings for ALMS and its competitors with MarketBeat's FREE daily newsletter. Email Address ALMS Media Mentions By Week ALMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALMS News Sentiment▼0.700.60▲Average Medical News Sentiment ALMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALMS Articles This Week▼63▲ALMS Articles Average Week Get Alumis News Delivered to You Automatically Sign up to receive the latest news and ratings for ALMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ABCL News REPL News COLL News RCKT News EOLS News PHVS News AVBP News COGT News OCS News BCYC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALMS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alumis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alumis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALMS Stock Alerts